ClinicalTrials.govpublic full text
A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma
multiple myeloma, relapsed and refractory, cc-99712, bcma, antibody drug conjugate, bms-986405, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 886501
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.